Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000676236 | SCV001150780 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | TRAP1: BS1, BS2 |
Labcorp Genetics |
RCV000676236 | SCV002442477 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676236 | SCV000801990 | uncertain significance | not provided | 2016-02-19 | no assertion criteria provided | clinical testing | |
Yale Center for Mendelian Genomics, |
RCV001849425 | SCV002106499 | pathogenic | Congenital anomaly of kidney and urinary tract | 2018-08-24 | no assertion criteria provided | literature only | |
Prevention |
RCV003938025 | SCV004752528 | likely benign | TRAP1-related disorder | 2021-01-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |